EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹48 Cr | ₹43 Cr | ₹40 Cr | ₹42 Cr | ₹66 Cr |
What is the latest Long Term Provisions ratio of EMCURE PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹42 Cr |
| Mar2021 | ₹66 Cr |
How is Long Term Provisions of EMCURE PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹48 Cr | 9.83 | |
| Mar2024 | ₹43 Cr | 9.21 | |
| Mar2023 | ₹40 Cr | -5.80 | |
| Mar2022 | ₹42 Cr | -36.14 | |
| Mar2021 | ₹66 Cr | - | |
Compare Long Term Provisions of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,650.3 Cr | 0.7% | -1.3% | 26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.7% |
-1.3% |
26.9% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses